Harwin Peter Evan 4
4 · Cogent Biosciences, Inc. · Filed Jun 11, 2026
Research Summary
AI-generated summary of this filing
Cogent (COGT) Director Harwin Evan Receives Stock Award
What Happened
Harwin Peter Evan, a director of Cogent Biosciences (COGT), received a grant of 17,901 derivative securities (stock options) on 2026-06-09. The reported acquisition price is $0, so there was no cash exchanged at grant. The options are an award (not a purchase or sale) and therefore do not represent an immediate change in market position.
Key Details
- Transaction date: 2026-06-09; Form 4 filed: 2026-06-11 (timely within the two-business-day window).
- Transaction type: A (Award/Grant of derivative securities).
- Shares/options granted: 17,901; reported price: $0 (no immediate cash value).
- Shares owned after transaction: Not specified in the provided filing.
- Footnotes of note:
- Vesting (F1): Options vest in full on the earlier of the first anniversary of grant or the 2027 Annual Meeting, subject to continued service.
- Beneficial ownership disclaimer (F2): The options are held for one or more investment vehicles managed by Fairmount Funds Management LLC; the reporting person disclaims beneficial ownership and must turn over any net cash or stock to the adviser for the funds.
Context
This was an option grant (award), not an exercise or sale. Because the options are held for Fairmount-managed funds and the director disclaims beneficial ownership, this filing reflects a grant to managed investment vehicles rather than clear personal buying/selling by the director. Grants are common for directors and compensate service; they do not by themselves indicate immediate buying pressure.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1][F2]2026-06-09+17,901→ 17,901 totalExercise: $31.98Exp: 2036-06-09→ Common Stock (17,901 underlying)
Footnotes (2)
- [F1]This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date.
- [F2]Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the "Adviser"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a "Fairmount Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.